Signe Søvik

Signe Søvik

Auto-generated profile, based on publicly available information

Signe Søvik

Akershus University Hospital

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2019 in Intensive Care Medicine
Verified
Journal Article
Closed access
SSSigne Søvik
Signe Søvik
MIMarie Susanna Isachsen
Marie Susanna Isachsen
KNKine Marie Nordhuus
Kine Marie Nordhuus
CTChristine Kooy Tveiten
Christine Kooy Tveiten
TETorsten Eken
Torsten Eken
SBSigrid Beitland
Sigrid Beitland

1 December 2020 in Circulation
Verified
Journal Article
Closed access
PDF file
Peder MyhrePeder Myhre
Peder Myhre
CPChristian Prebensen
Christian Prebensen
HSHeidi Strand
Heidi Strand
RRRagnhild Røysland
Ragnhild Røysland
CJChristine M. Jonassen
Christine M. Jonassen
TOTorbjørn Omland
Torbjørn Omland
Background: Growth differentiation factor 15 (GDF-15) is a strong prognostic marker in sepsis and cardiovascular disease (CVD). The prognostic value of GDF-15 in coronavirus disease 2019 (COVID-19) is unknown. Methods: Consecutive, hospitalized patients with laboratory-confirmed infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and symptoms of COVID-19 were enrolled in the prospective, observational COVID Mechanisms Study. Biobank samples were collected at baseline, day 3 and day 9. The primary end point was admission to the intensive care unit or death during hospitalization, and the prognostic performance of baseline and serial GDF-15 concentrations were compared with that of established infectious disease and cardiovascular biomarkers. Results: Of the 123 patients enrolled, 35 (28%) reached the primary end point; these patients were older, more often had diabetes, and had lower oxygen saturations and higher National Early Warning Scores on baseline. Baseline GDF-15 concentrations were elevated (>95th percentile in age-stratified healthy individuals) in 97 (79%), and higher concentrations were associated with detectable SARS-CoV-2 viremia and hypoxemia (both P <0.001). Patients reaching the primary end point had higher concentrations of GDF-15 (median, 4225 [IQR, 3197–5972] pg/mL versus median, 2187 [IQR, 1344–3620] pg/mL, P <0.001). The area under the receiver operating curve was 0.78 (95% CI, 0.70–0.86). The association between GDF-15 and the primary end point persisted after adjusting for age, sex, race, body mass index, estimated glomerular filtration rate, previous myocardial infarction, heart failure, and atrial fibrillation ( P <0.001) and was superior and incremental to interleukin-6, C-reactive protein, procalcitonin, ferritin, D-dimer, cardiac troponin T, and N-terminal pro-B-type natriuretic peptide. Increase in GDF-15 from baseline to day 3 was also greater in patients reaching the primary end point (median, 1208 [IQR, 0–4305] pg/mL versus median, –86 [IQR, –322 to 491] pg/mL, P <0.001). Conclusions: GDF-15 is elevated in the majority of patients hospitalized with COVID-19, and higher concentrations are associated with SARS-CoV-2 viremia, hypoxemia, and worse outcome. The prognostic value of GDF-15 was additional and superior to established cardiovascular and inflammatory biomarkers. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04314232.

2 June 2016 in Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
Verified
Journal Article
Open access
PDF file
BBBente Bilben
Bente Bilben
LGLinda Grandal
Linda Grandal
SSSigne Søvik
Signe Søvik
National Early Warning Score (NEWS) was designed to detect deteriorating patients in hospital wards, specifically those at increased risk of ICU admission, cardiac arrest, or death within 24 h. NEWS is not validated for use in Emergency Departments (ED), but emerging data suggest it may be useful. A criticism of NEWS is that patients with chronic poor oxygenation, e.g. severe chronic obstructive pulmonary disease (COPD), will have elevated NEWS also in the absence of acute deterioration, possibly reducing the predictive power of NEWS in this subgroup. We wanted to prospectively evaluate the usefulness of NEWS in unselected adult patients emergently presenting in a Norwegian ED with respiratory distress as main symptom. In respiratory distressed patients, NEWS was calculated on ED arrival, after 2–4 h, and the next day. Manchester Triage Scale (MTS) category, age, gender, comorbidity (ASA score), ICU-admission, ventilatory support, and discharge diagnoses were noted. Survival status was tracked for >90 days through the Population Registry. Data are medians (25–75th percentiles). Factors predicting 90-day survival were analysed with multiple logistic regression. We included 246 patients; 71 years old (60–80), 89 % home-dwelling, 74 % ASA 3–4, 72 % MTS 1–2, 88 % admitted to hospital. NEWS on arrival was 5 (3–7). NEWS correlated closely with MTS category and maximum in-hospital level of care (ED, ward, high-dependency unit, ICU). Sixteen patients died in-hospital, 26 died after discharge within 90 days. Controlled for age, ASA score, and COPD, a higher NEWS on ED arrival predicted poorer 90-day survival. Increased NEWS also correlated with decreased 30-day- and in-hospital survival and a decreased probability for home-dwelling patients to be discharged directly home. In respiratory distressed patients, NEWS on ED arrival correlated closely with triage category and need of ICU admission and predicted long-term out-of-hospital survival controlled for age, comorbidity, and COPD. NEWS should be explored in the ED setting to determine its role in clinical decision-making and in communication along the acute care chain.

1 November 2007 in Journal of Trauma: Injury, Infection & Critical Care
Verified
Journal Article
Closed access
NSNils O. Skaga
Nils O. Skaga
TETorsten Eken
Torsten Eken
SSSigne Søvik
Signe Søvik
JJJ Mary Jones
J Mary Jones
PSPetter A. Steen
Petter A. Steen
The ability of an organism to withstand trauma is determined by the injury per se and inherent properties of the organism at the time of injury. We analyzed whether pre-injury morbidity scored on a four-level ordinal scale according to the American Society of Anesthesiologists Physical Status (ASA-PS) classification system predicts mortality after trauma. From a total of 3,773 prospectively collected patients (years 2000-2004), 3,728 patients were included. Main outcome measure was mortality 30 days after injury. The effect of pre-injury ASA-PS on mortality was assessed using linear logistic regression analysis, controlling for Revised Trauma Score (RTS), Injury Severity Score (ISS), and age. Mortality increased with increasing pre-injury ASA-PS, age, and ISS, and with decreasing RTS. Unadjusted mortality rates were 5.7% in ASA-PS 1, 12.3% in ASA-PS 2, and 26.4% in ASA-PS 3-4. This increasing mortality trend across pre-injury ASA-PS group was evident in nearly all categories of ISS, RTS, and age. Odds ratio for death was 1.76 (95% CI, 1.14-2.72) for pre-injury ASA-PS 2, and 2.25 (95% CI, 1.36-3.71) for ASA-PS 3-4 compared with for ASA-PS 1 and adjusted for ISS, RTS, and age. There were no interaction effects between pre-injury ASA-PS and the other variables. Pre-injury ASA-PS score was an independent predictor of mortality after trauma, also after adjusting for the major variables in the traditional TRISS (Trauma and Injury Severity Score) formula. Including pre-injury ASA-PS score might improve the predictive power of a survival prediction model without complicating it.

1 September 2020 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
WOWilliam Ottestad
William Ottestad
SSSigne Søvik
Signe Søvik

21 May 2022 in Journal of Infection
Verified
Journal Article
Open access
SSSigne Søvik
Signe Søvik
ABAndreas Barratt-Due
Andreas Barratt-Due
TKTrine Kåsine
Trine Kåsine
TOTheresa Olasveengen
Theresa Olasveengen
MSMarianne Wigernes Strand
Marianne Wigernes Strand
INIngvild Nordøy
Ingvild Nordøy
To determine the incidence and characteristics of superinfections in mechanically ventilated COVID-19 patients, and the impact of dexamethasone as standard therapy. This multicentre, observational, retrospective study included patients ≥ 18 years admitted from March 1st 2020 to January 31st 2021 with COVID-19 infection who received mechanical ventilation. Patient characteristics, clinical characteristics, therapy and survival were examined. 155/156 patients (115 men, mean age 62 years, range 26-84 years) were included. 67 patients (43%) had 90 superinfections, pneumonia dominated (78%). Superinfections were associated with receiving dexamethasone (66% vs 32%, p<0.0001), autoimmune disease (18% vs 5.7%, p<0.016) and with longer ICU stays (26 vs 17 days, p<0,001). Invasive fungal infections were reported exclusively in dexamethasone-treated patients [8/67 (12%) vs 0/88 (0%), p<0.0001]. Unadjusted 90-day survival did not differ between patients with or without superinfections (64% vs 73%, p=0.25), but was lower in patients receiving dexamethasone versus not (58% vs 78%, p=0.007). In multiple regression analysis, superinfection was associated with dexamethasone use [OR 3.7 (1.80–7.61), p<0.001], pre-existing autoimmune disease [OR 3.82 (1.13–12.9), p=0.031] and length of ICU stay [OR 1.05 p<0.001]. In critically ill COVID-19 patients, dexamethasone as standard of care was strongly and independently associated with superinfections.